Demographic, Clinical, and Laboratory Characteristics of Children With Third-Generation Cephalosporin-Resistant UTIs Started on Discordant Antibiotic Therapy
| . | N = 316 . |
|---|---|
| Sex, n (%) | |
| Male | 69 (21.8) |
| Female | 247 (78.2) |
| Age, median (IQR) | 2.4 (0.6–6.5) |
| Age category, n (%) | |
| <2 mo | 24 (7.6) |
| 2–23 mo | 123 (38.9) |
| 2–4 y | 65 (20.6) |
| 5–17 y | 104 (32.9) |
| History of VUR or renal abnormalities, n (%) | 16 (5.1) |
| Previous UTI, n (%) | 65 (20.6) |
| Previous third-generation cephalosporin-resistant UTI, n (%) | 3 (1.0) |
| Setting of initial evaluation, n (%) | |
| General pediatrics or urgent care clinic | 137 (43.4) |
| ED | 178 (56.3) |
| Inpatient | 1 (0.3) |
| Ill appearance, n (%) | 8 (2.5) |
| Presenting symptoms, n (%) | |
| Fever | 201 (63.6) |
| Nausea and/or vomiting | 73 (23.1) |
| Poor oral intake | 64 (20.3) |
| Fussiness and/or irritability | 39 (12.3) |
| Abdominal and/or back pain | 52 (16.4) |
| Dysuria | 113 (35.8) |
| Abnormal urine odor | 48 (15.2) |
| Urine culture organism, n (%) | |
| E coli | 312 (98.7) |
| Klebsiella spp. | 4 (1.3) |
| Urine culture colony count, n (%) | |
| 50 000–100 000 CFU/mL | 48 (15.2) |
| >100 000 CFU/mL | 268 (84.8) |
| Urine culture collection method, n (%) | |
| Straight catheterization | 134 (42.4) |
| Clean catch | 164 (51.9) |
| Not documented | 18 (5.7) |
| Hospitalized on initial presentation, n (%) | 44 (13.9) |
| Method of follow-up, n (%) | |
| Phone follow-up | 226 (71.8) |
| Outpatient or ED visit | 25 (7.9) |
| Inpatient admission | 64 (20.3) |
| Clinical response information available at the time of follow-up, n (%) | 230 (72.8) |
| . | N = 316 . |
|---|---|
| Sex, n (%) | |
| Male | 69 (21.8) |
| Female | 247 (78.2) |
| Age, median (IQR) | 2.4 (0.6–6.5) |
| Age category, n (%) | |
| <2 mo | 24 (7.6) |
| 2–23 mo | 123 (38.9) |
| 2–4 y | 65 (20.6) |
| 5–17 y | 104 (32.9) |
| History of VUR or renal abnormalities, n (%) | 16 (5.1) |
| Previous UTI, n (%) | 65 (20.6) |
| Previous third-generation cephalosporin-resistant UTI, n (%) | 3 (1.0) |
| Setting of initial evaluation, n (%) | |
| General pediatrics or urgent care clinic | 137 (43.4) |
| ED | 178 (56.3) |
| Inpatient | 1 (0.3) |
| Ill appearance, n (%) | 8 (2.5) |
| Presenting symptoms, n (%) | |
| Fever | 201 (63.6) |
| Nausea and/or vomiting | 73 (23.1) |
| Poor oral intake | 64 (20.3) |
| Fussiness and/or irritability | 39 (12.3) |
| Abdominal and/or back pain | 52 (16.4) |
| Dysuria | 113 (35.8) |
| Abnormal urine odor | 48 (15.2) |
| Urine culture organism, n (%) | |
| E coli | 312 (98.7) |
| Klebsiella spp. | 4 (1.3) |
| Urine culture colony count, n (%) | |
| 50 000–100 000 CFU/mL | 48 (15.2) |
| >100 000 CFU/mL | 268 (84.8) |
| Urine culture collection method, n (%) | |
| Straight catheterization | 134 (42.4) |
| Clean catch | 164 (51.9) |
| Not documented | 18 (5.7) |
| Hospitalized on initial presentation, n (%) | 44 (13.9) |
| Method of follow-up, n (%) | |
| Phone follow-up | 226 (71.8) |
| Outpatient or ED visit | 25 (7.9) |
| Inpatient admission | 64 (20.3) |
| Clinical response information available at the time of follow-up, n (%) | 230 (72.8) |
VUR, vesicoureteral reflux.